Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 1.8T | 1.8T | 1.8T |
Cost of revenue | — | 1.5T | 1.5T | 1.5T |
Gross profit | — | 289.3B | 298.6B | 274.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 149.0B | 276.1B | 158.3B |
Other operating expenses | — | 20.2B | 10.9B | 7.0B |
Operating income | — | 142.0B | 26.8B | 117.4B |
Non operating interest income | ||||
Income | — | 12.1B | 29.4B | 8.6B |
Expense | — | 2.2B | 8.5B | 6.0B |
Other income expense | — | — | — | — |
Pretax income | — | 147.5B | 41.1B | 118.4B |
Tax provision | — | -1.3B | 19.9B | 25.5B |
Net income | — | 148.8B | 21.2B | 92.9B |
Basic EPS | 32.5 | — | 2.2 | 7.0 |
Diluted EPS | 32.5 | — | 2.2 | 7.0 |
Basic average shares | 2.9B | — | 3.0B | 12.0B |
Diluted average shares | 2.9B | — | 3.0B | 12.0B |
EBITDA | — | 243.7B | 142.8B | 218.9B |
Net income from continuing op. | — | 147.5B | 41.1B | 118.4B |
Minority interests | — | -11.6B | -14.5B | -9.4B |
Preferred stock dividends | — | 0 | 0 | 0 |